XML 43 R23.htm IDEA: XBRL DOCUMENT
v3.22.4

Capital Stock | 12 Months Ended
--- | ---
Dec. 31, 2022
Equity [Abstract] |
CAPITAL STOCK | CAPITAL STOCK At December 31, 2022, there were 900,000,000 shares of common stock and 30,000,000 shares of serial preferred stock authorized for issuance. Of the authorized serial preferred stock, 3,000,000 shares are designated as cumulative redeemable serial preferred stock. Under the 2006 Equity and Performance Incentive Plan (2006 Employee Plan), 71,100,000 shares may be issued or transferred. An aggregate of 17,939,143, 19,135,222 and 21,007,911 shares of common stock at December 31, 2022, 2021 and 2020, respectively, were reserved for the exercise and future grants of option rights and future grants of restricted stock and restricted stock units. See Note 15 for additional information related to stock-based compensation. Shares outstanding shown in the following table included 1,426,883, 1,426,883 and 1,469,712 shares of common stock held in a revocable trust at December 31, 2022, 2021 and 2020, respectively. The revocable trust is used to accumulate assets for the purpose of funding the ultimate obligation of certain non-qualified benefit plans. Transactions between the Company and the trust are accounted for in accordance with the Deferred Compensation – Rabbi Trusts Subtopic of the Compensation Topic of the ASC, which requires the assets held by the trust be consolidated with the Company’s accounts.
| Shares in Treasury |  | Shares Outstanding
Balance at January 1, 2020 | 81,866,907 |  |  | 276,434,517 |
Shares issued for exercise of option rights |  |  | 2,873,646 |
Shares tendered as payment for option rights exercised | 10,140 |  |  | (10,140) |
Shares issued for vesting of restricted stock units |  |  | 386,685 |
Shares tendered in connection with vesting of restricted stock units | 133,077 |  |  | (133,077) |
Treasury stock purchased | 11,700,000 |  |  | (11,700,000) |
Treasury stock retired | (91,746,432) |  |  |
Treasury stock sold (1) | (825,000) |  |  | 825,000 |
Balance at December 31, 2020 | 1,138,692 |  |  | 268,676,631 |
Shares issued for exercise of option rights |  |  | 2,365,168 |
Shares tendered as payment for option rights exercised | 4,324 |  |  | (4,324) |
Shares issued for vesting of restricted stock units |  |  | 276,948 |
Shares tendered in connection with vesting of restricted stock units | 95,618 |  |  | (95,618) |
Treasury stock purchased | 10,075,000 |  |  | (10,075,000) |
Balance at December 31, 2021 | 11,313,634 |  |  | 261,143,805 |
Shares issued for exercise of option rights |  |  | 778,075 |
Shares tendered as payment for option rights exercised | 3,861 |  |  | (3,861) |
Shares issued for vesting of restricted stock units |  |  | 357,832 |
Shares tendered in connection with vesting of restricted stock units | 124,852 |  |  | (124,852) |
Treasury stock purchased | 3,350,000 |  |  | (3,350,000) |
Treasury stock sold (1) | (75,000) |  |  | 75,000 |
Balance at December 31, 2022 | 14,717,347 |  |  | 258,875,999 |
(1) During the years ended December 31, 2020 and 2022, the Company sold treasury shares to fund Company contributions to the domestic defined contribution plan. The related proceeds were $182.4 million and $22.0 million, respectively.

X
- Definition -- None. No documentation exists for this element. -- + References No definition available. + Details
Name: | shw_CapitalStockTextBlock
Namespace Prefix: | shw_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_EquityAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration